Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxophylline as Steroid-Sparing Treatment in Pediatric Asthma
NCT03879590Phase 3Unknown
- Sponsor
- Universidad Autónoma de Nuevo León
- Start
- May 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of doxofylline in asthma (2 arms), sponsored by Universidad Autónoma de Nuevo León. Primary endpoint: Forced Expiratory Volume in 1 Second at 4 weeks. Status: unknown.
02
Drugs
doxofylline
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03879590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03879590.